RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Takeda Pharmaceutical Co P/S 2024

Takeda Pharmaceutical Co P/S

1.6

Takeda Pharmaceutical Co Dividend yield

4.38 %

Ticker

4502.T

ISIN

JP3463000004

WKN

853849

As of May 15, 2024, Takeda Pharmaceutical Co's P/S ratio stood at 1.6, a -6.98% change from the 1.72 P/S ratio recorded in the previous year.

The Takeda Pharmaceutical Co P/S history

Takeda Pharmaceutical Co Aktienanalyse

What does Takeda Pharmaceutical Co do?

Takeda Pharmaceutical Co Ltd is a Japanese company that operates in the pharmaceutical industry. The company was founded in 1781 by Chobei Takeda as a traditional pharmacy specializing in herbal medicine. Nowadays, the company is a leading player in the global pharmaceutical industry. Business model: Takeda aims to help people worldwide through the development of groundbreaking therapies and drugs. The company has a strong research and development department that focuses on the discovery of new therapies and the improvement of existing medications. Takeda has made global partnerships and acquisitions to leverage the combination of science and technology and ensure better patient care. Divisions: Takeda operates in four main divisions: Gastrointestinal (GI), Oncology, Rare Diseases, and Neuroscience. In the GI division, the company is a global leader in the treatment of gastrointestinal diseases such as Crohn's disease and ulcerative colitis. The Oncology division aims to develop novel cancer therapies and provide patients with a higher quality of life. The Rare Diseases division specializes in the development of medications for rare diseases. The Neuroscience division focuses on developing medications to combat nervous system disorders such as Alzheimer's and Parkinson's. Products: Takeda's product range includes a variety of medications used worldwide to treat various diseases. One example is enzyme replacement therapy, which is administered to patients with a rare disease. Another example is Entyvio, a medication used to treat Crohn's disease and ulcerative colitis. Takeda also has medications in the Oncology division, such as Adcetris, a therapeutic agent against certain lymphomas and leukemia. In summary, Takeda Pharmaceutical Co Ltd is a leading company in the global pharmaceutical industry. The company's business model is based on the development of groundbreaking therapies and medications to improve patient care. With a focus on the GI, Oncology, Rare Diseases, and Neuroscience divisions, Takeda offers a variety of products for the treatment of various diseases. Takeda Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Takeda Pharmaceutical Co's P/S Ratio

Takeda Pharmaceutical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Takeda Pharmaceutical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Takeda Pharmaceutical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Takeda Pharmaceutical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Takeda Pharmaceutical Co Stock

What is the price-to-earnings ratio of Takeda Pharmaceutical Co?

The price-earnings ratio of Takeda Pharmaceutical Co is currently 1.6.

How has the price-earnings ratio of Takeda Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Takeda Pharmaceutical Co has increased by -6.98% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Takeda Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Takeda Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Takeda Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Takeda Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Takeda Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Takeda Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Takeda Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Takeda Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Takeda Pharmaceutical Co pay?

Over the past 12 months, Takeda Pharmaceutical Co paid a dividend of 184 JPY . This corresponds to a dividend yield of about 4.38 %. For the coming 12 months, Takeda Pharmaceutical Co is expected to pay a dividend of 177.52 JPY.

What is the dividend yield of Takeda Pharmaceutical Co?

The current dividend yield of Takeda Pharmaceutical Co is 4.38 %.

When does Takeda Pharmaceutical Co pay dividends?

Takeda Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Takeda Pharmaceutical Co?

Takeda Pharmaceutical Co paid dividends every year for the past 24 years.

What is the dividend of Takeda Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 177.52 JPY are expected. This corresponds to a dividend yield of 4.22 %.

In which sector is Takeda Pharmaceutical Co located?

Takeda Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Takeda Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Takeda Pharmaceutical Co from 6/1/2024 amounting to 94 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Takeda Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Takeda Pharmaceutical Co in the year 2023?

In the year 2023, Takeda Pharmaceutical Co distributed 180 JPY as dividends.

In which currency does Takeda Pharmaceutical Co pay out the dividend?

The dividends of Takeda Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Takeda Pharmaceutical Co stock can be added to a savings plan with the following providers: Consorsbank

Andere Kennzahlen von Takeda Pharmaceutical Co

Our stock analysis for Takeda Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takeda Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.